USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
Tripos, Inc.
Address:
Tripos, Inc.
1699 S Hanley Rd
Saint Louis, MO 63144
Phone:
(314) 647-1099
URL:
N/A
EIN:
431454986
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $305,807.00 5
SBIR Phase II $1,717,726.00 3

Award List:

CORRELATION OF DYNAMIC MOLECULAR SHAPE WITH ACTIVITY

Award Year / Program / Phase:
1984 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Richard D. Cramer , Vice President
Abstract:
N/a

IN CANCER CLINICAL TRIALS^ADAPTATION OF DABYL REPEATABLE RADIOTHERAPY, AND REDUCE THERAPIST SETUP TIMES.

Award Year / Program / Phase:
1985 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Richard cramer , PRINCIPAL INVESTIGATOR
Abstract:
In cancer clinical trials^adaptation of dabyl repeatable radiotherapy, and reduce therapist setup times.tripos is the leading supplier of interactive 3-d graphics-based molecular modeling software, used primarily in pharmaceutical research. in collaboration with jeri1, tripos has also been… More

CORRELATION OF DYNAMIC MOLECULAR SHAPE WITH ACTIVITY

Award Year / Program / Phase:
1986 / SBIR / Phase II
Award Amount:
$500,000.00
Agency:
HHS
Principal Investigator:
Richard D. Cramer , Vice President
Abstract:
Improvements in correlating biological activity with its most important determinant, molecular shape, should improve the efficiency of drug discovery. a particularly promising method of shape correlation, "dylomms", has been applied at sk&f to elucidate the gaba uptake receptor requirements. its key… More

VISUALIZING THOUSAND-DIMENSIONAL CHEMICAL DIVERSITY

Award Year / Program / Phase:
1998 / SBIR / Phase I
Award Amount:
$66,895.00
Agency:
HHS
Principal Investigator:
Patterson, David E
Abstract:
N/a

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase I
Award Amount:
$0.00
Agency:
HHS
Principal Investigator:
David E. Patterson
Abstract:
N/a

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase II
Award Amount:
$370,631.00
Agency:
HHS
Principal Investigator:
David E. Patterson
Abstract:
N/a

Topomer selection among all accessible structures

Award Year / Program / Phase:
2003 / SBIR / Phase I
Award Amount:
$138,912.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The objective is a general methodology for using knowledge of one or more active ligands to select from among the vast realm of all synthetically accessible structures the most promising compounds for some particular therapeutic objective. A novel topomeric… More

Topomer selection by chemists from All structures

Award Year / Program / Phase:
2005 / SBIR / Phase II
Award Amount:
$847,095.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The overall objective is a general methodology for using knowledge of one or more active ligands to select from among the vast realm of all synthetically accessible structures the most promising compounds for some particular therapeutic objective, to be used by… More